| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |